Secoisolariciresinol Diglucoside (SDG) Blocks Muscarinic Receptor-Mediated NLRP3 Inflammasome Activation in Cardiomyocytes
Background
The NLRP3 inflammasome is a critical mediator in inflammatory pathways, playing a key role in cardiovascular disease progression and representing a promising target for cardioprotective interventions. While secoisolariciresinol diglucoside (SDG), a flaxseed lignan, is known for its cardioprotective effects, its precise molecular mechanism remains largely unknown. This study addresses this gap by investigating SDG's immunomodulatory role in regulating muscarinic acetylcholine receptor-mediated activation of the NLRP3 inflammasome, a pathway implicated in inflammation.
Study Design
HL-1 mouse cardiomyocytes were treated with carbachol, a cholinergic agonist, to induce inflammation. The study investigated the effects of preconditioning with SDG, an NF-κB inhibitor, or specific acetylcholine receptor antagonists. Expression and activation of NLRP3 family members (NLRP3, ASC, Caspase-1, IL-18, IL-1beta) were analyzed. NLRP3 components and NF-κB activation were assessed using immunostaining and immunofluorescence. Functional endpoints of NLRP3 activation, including Caspase-1 activity and gasdermin D expression, were also studied.
Results
Carbachol successfully induced the activation of NLRP3 inflammasomes in HL-1 cardiomyocytes, confirming its pro-inflammatory effect via the cholinergic system. Pre-treatment with SDG significantly attenuated this carbachol-induced activation of the NLRP3 inflammasome. This protective effect was comparable to interventions targeting known inflammatory pathways. The study also found that NLRP3 activation was subdued in the presence of atropine, a muscarinic receptor antagonist, and an NF-κB activation inhibitor. This confirms the crucial role of the muscarinic receptor and the NF-κB pathway in mediating this inflammatory response. These findings highlight a novel mechanism for SDG's cardioprotective properties.
SDG significantly attenuated carbachol-induced activation of the
NLRP3inflammasome in HL-1 cardiomyocytes.
Key Findings
- Carbachol activates the
NLRP3inflammasome in HL-1 mouse cardiomyocytes. - Secoisolariciresinol diglucoside (SDG) significantly attenuates carbachol-induced
NLRP3inflammasome activation. - Muscarinic acetylcholine receptors mediate the activation of the
NLRP3inflammasome. - The
NF-κBpathway is involved inNLRP3inflammasome activation in cardiomyocytes. - The muscarinic cholinergic system exhibits pro-inflammatory properties in this context.
Why It Matters
This research provides a novel mechanistic understanding of how secoisolariciresinol diglucoside (SDG) exerts its cardioprotective effects, specifically through inhibiting the NLRP3 inflammasome. For individuals interested in natural anti-inflammatory strategies, SDG from flaxseed emerges as a promising agent for mitigating inflammation in cardiovascular contexts. It also sheds light on the pro-inflammatory role of the muscarinic cholinergic system, contrasting with the known anti-inflammatory effects of the nicotinic system, which could inform future drug development. While this is an in-vitro study, it lays the groundwork for exploring SDG as a therapeutic or dietary intervention to prevent NLRP3-induced inflammation, potentially impacting protocols for managing chronic inflammatory conditions.
secoisolariciresinol-diglucoside
sdg
nlrp3
inflammasome
anti-inflammatory
cardiovascular-disease